Case Study: Sera Medicines boosts secure, efficient biopharma due diligence with iDeals data rooms

Sera Medicines finances 2 companies in a year with iDeals

Sera Medicines, a biologics-focused accelerator that licenses next-generation protein therapeutics, required a highly secure and efficient virtual data room to manage its sensitive drug development lifecycle. They faced challenges with previous providers that were cumbersome and expensive, and they needed a solution from a vendor like iDeals that could guarantee state-of-the-art security for proprietary data, including sensitive FDA correspondence, while being easy to use for due diligence, R&D, and investor communications.

The solution implemented was the iDeals virtual data room, which enabled the team to quickly set up multiple secure rooms, set granular user permissions, and run detailed activity reports. The results were highly successful, with William Bonificio describing the platform as a "revelation" and the best data room he has ever used. iDeals facilitated a smooth and rigorous reverse merger process and is now the trusted platform Sera Medicines uses for all its new companies, making fundraising and licensing efforts incredibly easy and seamless.

Sera Medicines